Importance of Rebates and Future of Biosimilar Market | AMCP Nexus 2024
An optimistic outlook on the future of the biosimilar market driving down pharmaceutical drug spend.
In this discussion, Javier Gonzalez, Pharm.D., chief growth and commercial officer of Abarca, highlights the critical role of rebates in maintaining affordable health plan premiums and accessibility of specialty drugs.
“A lot of people say that the biosimilar space is at risk - I don't believe that,” Gonzalez said. “I think it will continue to be one of the main drivers of lowering our overall pharmaceutical drug spend over the next five to 10 years.”
Abarca is a health IT company and pharmacy benefit manager. Gonzalez co-led the session, ‘Are Patients Getting a Fair Share of the Value of Biosimilars?’ today at AMCP Nexus, held at the MGM Grand in Las Vegas.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
